Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PDS Q407 Income statement

PDS Q407 Income statement

posted on Aug 14, 2007 02:43PM

  

PDS Income Statement  Q407 
Licenses     43,090,000
Expenses       4,894,471
Interest         112,104
Tax Provision          11,790
Net PDS income     38,295,843
50/50 split to PTSC    19,147,922
PDS Breakdown     43,090,000
Sandisk    13,420,000  (my estimate) 
Sharp      8,720,000  (my estimate) 
Nokia    20,950,000  (actual) 

 

   Shares Repurchased   Amount  Price Per share 
FY06                  4,874,827  $        4,024,395  $              0.83
                 3,132,500  $        1,960,305  $              0.63
                 2,771,700  $        1,456,964  $              0.53
Q407                  2,688,500  $        1,396,235  $              0.52
Q108                  4,961,640  $        2,725,793  $              0.55
Total                 18,429,167  $      11,563,692  $              0.63

Aug 14, 2007 02:59PM
Share
New Message
Please login to post a reply